摘要:
The invention relates to methods for treating type 2 diabetes, obesity, metabolic syndrome and conditions associated with these by administering an AICAR-monophosphate (AICAR-MP) enhancing agent that increases endogenous AICAR-MP levels in a cell. Inhibition of AICAR-formyltransferase activity (AICARFT) in a cell that regulates metabolic activity (such as fat, liver, muscle, pancreatic beta or certain brain cells) increases AICAR-monophosphate levels which in turn results in activation of the AMP-kinase (AMPK) pathway, and all of the downstream functions mediated by AMPK including increased fatty acid oxidation, enhanced glucose transport and decreased fatty acid synthesis.
摘要:
The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
摘要:
The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
摘要:
An apparatus for delivering ultrasound energy and a drug solution to a treatment site in a vessel is disclosed. The apparatus includes an elongate, hollow sheath having a distal opening and an energy delivery section at least partially constructed from a material that transmits ultrasound energy. The apparatus also includes a drug delivery lumen positioned along at least a portion of the sheath, the drug delivery lumen having at least one drug delivery port within the energy delivery section. The apparatus further includes an elongate body having an ultrasound element, the elongate body configured to be movably positioned within the sheath, such that ultrasonic energy can be transmitted from the ultrasound element through the energy delivery section.
摘要:
A cartridge for use with a blood vessel access system and device. The cartridge includes a slideable needle mount and a slideable cannula mount, the slideable needle mount having a needle in slideable connection with a lumen of a cannula held by the needle mount. The slideable needle mount and the slideable cannula mount are removeably attachable with separate moveable platforms of a needle injector that is pivotally attached to a handheld ultrasound transceiver in signal communication with a computer processing unit connected with a monitor. Upon insonification of a patient's vasculature using the handheld ultrasound transceiver pressed against the surface of the patient, needle injection and subsequent cannulation of a targeted blood vessel appearing on the monitor is accomplished by deploying the needle and cannula from the cartridge via motorization of the moveable platforms that is initiated by the user operating a controller on the device's needle injector.
摘要:
The present invention relates to compositions and the prevention and treatment of circulatory conditions. In one embodiment, the present invention contemplates a compositions comprising anti-platelet aggregating activity. In another embodiment, the present invention contemplates methods to prevent or treat vascular or cardiovascular diseases. In another embodiment, the present invention relates to a method to prevent or treat cardiovascular disease by administering a glycerol saccharide derivative, an arylpolyphenol, a saccharide substituted with an arylpolyphenol, or a steroid substituted with an arylpolyphenol capable of reducing platelet aggregation. In one embodiment, the invention relates to a method of using the compounds capable of reducing platelet aggregation in order to prevent the recurrence of a heart attack by administration of the compounds to a subject after the subject has experienced a heart attack.
摘要:
A building automation and control network (BACnet) master-slave/token-passing (MS/TP) automatic media access control (MAC) addressing system having a BACnet MS/TP network, a MAC assigner on the network, and one or more MAC assignees on the network. Each assignee may have a global unique identity (GUID) and the assigner may have a pre-defined address. The assigner may gather virtually all GUIDs of the MAC assignees on the network and gather virtually all unused MAC addresses on the network. The assigner may map GUIDs to the unused MAC addresses and send a resulting map to the MAC assignees for assignment of a MAC address to each assignee. Each assignee may be assigned a MAC address according to its GUID, and the assignment of a MAC address to each assignee may occur automatically without manual intervention. In other words, the system may provide auto MAC addressing.
摘要:
An access system and device having a needle injector pivotally attached to an ultrasound transceiver is operated to place a sterilizable needle or needle/cannula unit within a blood vessel by a single user-device operator in which the blood vessel is made visible in a monitor image by ultrasound insonification. A guidance template having an expected path trajectory is overlapped on at least one of a transverse short axis, a longitudinal long axis, or a three-dimensionally imaged blood vessel that illustrates the predicted path of the needle or needle with overlapping cannula when it undergoes movement implemented by a controller located on the needle injector. In alternate embodiments the needle injector, ultrasound transceiver, and needle or needle/cannula unit may be contained within a flexible sheath that is capable of being sterilized.
摘要:
The present disclosure provides a brachytherapy apparatus, system and method that delivers partial breast irradiation treatment for post-lumpectomy patients via introduction of a catheter-like device through a trocar. The apparatus may be introduced post-surgically with local anesthesia under image guidance into the previous excision site and into a cavity by a surgeon. The brachytherapy apparatus includes one or more thin-walled tubes, each of said thin-walled tubes being configured to contain one or more radioactive sources, at least one radiation source configured to deliver a prescribed dose of radiation, a whisk adjuster configured to permit adjustment of each of the one or more thin-walled tubes so that the tubes substantially conform to a size of the body cavity; and an expansion element configured to expand outwardly said one or more thin-walled tubes within the cavity so that the thin-walled tubes substantially conform to a shape and/or size of the body cavity.